Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies
The DOI matches its Crossref record; 117 of the 119 references it cites were found in a registry or an index.
Abstract
In human immunodeficiency virus (HIV)-infected patients, Pneumocystis jirovecii pneumonia (PCP) is a well-known opportunistic infection, and its management has been established. However, PCP is an emerging threat to immunocompromised patients without HIV infection, such as those receiving novel immunosuppressive therapeutics for malignancy, organ transplantation, or connective tissue diseases. Clinical manifestations of PCP are quite different between patients with and without HIV-infections. In patients without HIV infection, PCP rapidly progresses, is difficult to diagnose correctly, and causes severe respiratory failure with a poor prognosis. High-resolution computed tomography findings are different between PCP patients with HIV infection and those without. These differences in clinical and radiologic features are the result of severe or dysregulated inflammatory responses that are evoked by a relatively small number of Pneumocystis organisms in patients without HIV infection. In recent years, the usefulness of PCR and serum β-D-glucan assay for rapid and noninvasive diagnosis of PCP has been revealed. Although corticosteroid adjunctive to anti-Pneumocystis agents has been shown to be beneficial in some populations, the optimal dose and duration remain to be determined. Recent investigations revealed that Pneumocystis colonization is prevalent, and that asymptomatic carriers are at riskfor developing PCP and can serve as the reservoir for the spread of Pneumocystis by person-to-person transmission. These findings suggest the need for chemoprophylaxis in immunocompromised patients without HIV infection, although its indication and duration are still controversial. Because a variety of novel immunosuppressive therapeutics have been emerging in medical practice, further innovations in the diagnosis and treatment of PCP are needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, the increasing use of immunosuppressant drugs, their use in high doses or their combination has increased numbers of PCP cases in patients with solid tumours, haematological malignancies, rheumatic diseases or organ transplant recipients [128,129].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [128]
In the citing paper
“As this microorganism cannot be cultured in laboratory conditions, direct examination and immunofluorescence are used as reference methods with sensitivity rates higher than 90% [128,131], or PCR methods in developed countries [132].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [128]
Citations
Cites
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
Kasiske, B. L., Zeier, M. G., Chapman, J. R., Craig, J. C., Ekberg, H., Garvey, C. A., Green, M. D., Jha, V., Josephson, M. A., Kiberd, B. A., et al. (2010) · Kidney International · doi:10.1038/ki.2009.377 · Cited by 1,735
Kaplan, J. E., Benson, C., Holmes, K. K., Brooks, J. T., Pau, A., & Masur, H. (2009) · PsycEXTRA Dataset · doi:10.1037/e537722009-001 · Cited by 1,343
Thomas, C. F., & Limper, A. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032588 · Cited by 1,037
KOVACS, J. A., HIEMENZ, J. W., MACHER, A. M., STOVER, D., MURRAY, H. W., SHELHAMER, J., LANE, H. C., URMACHER, C., HONIG, C., LONGO, D. L., et al. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-5-663 · Cited by 855
Phair, J., Muñoz, A., Detels, R., Kaslow, R., Rinaldo, C., Saah, A., & the Multicenter AIDS Cohort Study Group* (1990) · New England Journal of Medicine · doi:10.1056/nejm199001183220304 · Cited by 684
Yale, S. H., & Limper, A. H. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.1.5 · Cited by 644
(2000) · Biology of Blood and Marrow Transplantation · doi:10.1016/s1083-8791(00)70002-4 · Cited by 607
Limper, A. H., Offord, K. P., Smith, T. F., & Martin, W. J. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.5.1204 · Cited by 494
A New Name for Pneumocystis from Humans and New Perspectives on the Host-Pathogen Relationship
Stringer, J. R., Beard, C. B., Miller, R. F., & Wakefield, A. E. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0809.020096 · Cited by 490
Pneumocystis carinii Infection: Evidence for High Prevalence in Normal and Immunosuppressed Children
Pifer, L. L., Hughes, W. T., Stagno, S., & Woods, D. (1978) · Pediatrics · doi:10.1542/peds.61.1.35 · Cited by 434
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“In addition, the increasing use of immunosuppressant drugs, their use in high doses or their combination has increased numbers of PCP cases in patients with solid tumours, haematological malignancies, rheumatic diseases or organ transplant recipients [128,129].”
BackgroundMethodPneumocystis jirovecii Pneumonia in Patients with or without AIDS, France
Roux, A., Canet, E., Valade, S., Gangneux-Robert, F., Hamane, S., Lafabrie, A., Maubon, D., Debourgogne, A., Le Gal, S., Dalle, F., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2009.131668 · Cited by 319
Kretchy, I. A., Asiedu-Danso, M., & Kretchy, J.-P. (2021) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.04.007 · Cited by 301
Cooley, L., Dendle, C., Wolf, J., Teh, B. W., Chen, S. C., Boutlis, C., & Thursky, K. A. (2014) · Internal Medicine Journal · doi:10.1111/imj.12599 · Cited by 228
Fauchier, T., Hasseine, L., Gari-Toussaint, M., Casanova, V., Marty, P., & Pomares-Estran, C. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.03174-15 · Cited by 164
Metadata
- Authors
- Tasaka, S., & Tokuda, H.
- Affiliations
- Keio University (JP)
- Corresponding author
- Tasaka, Sadatomo
- Venue
- Journal of Infection and Chemotherapy
- Publisher
- Elsevier BV
- Published
- 2012
- Volume
- 18
- Issue
- 6
- Pages
- 793-806
- ISSN
- 1341-321X (ISSN-L)
- OpenAlex
- W2105078649
- Cited by
- 123
- References
- 119
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 5 · 2023: 10 · 2022: 8 · 2021: 10 · 2020: 7 · 2019: 4 · 2018: 6 · 2017: 9 · 2016: 19 · 2015: 13 · 2014: 17 · 2013: 4 · 2012: 1
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Infection and Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Pneumocystis jirovecii pneumonia detection and treatment
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Pneumocystis carinii pneumonia, non-HIV immunocompromised patients, opportunistic infections, high-resolution computed tomography, PCR diagnosis, Pneumocystis colonization, asymptomatic carriers, chemoprophylaxis, organ transplantation, hematologic malignancies, connective tissue diseases, respiratory failure
- MeSH terms
- Humans, Immunocompetence, Immunosuppressive Agents, Pneumonia, Pneumocystis, HIV Infections, Communicable Diseases, Emerging, Pneumocystis carinii
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies. https://app.cochat.ai/papers/10.1007/s10156-012-0453-0
- The paper
- Tasaka, S., & Tokuda, H. (2012). Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies. Journal of Infection and Chemotherapy. https://doi.org/10.1007/s10156-012-0453-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.